Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.

The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a ...

Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that ...

Your family doctor might refer you to an oncologist or hematologist-- specialists who diagnose and treat leukemia. The doctor will do tests to find out if you have AML and which type you have.

Acute myeloid leukemia is a type of cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer develops from myeloid blasts cells that would ...

Acute myeloid leukemia (AML) is one of the most aggressive and genetically complex cancers, marked by the unchecked growth of ...

The following is a summary of “Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations,” published in the February 2025 issue of the International Journal of ...

Special tissues in these organs are important for the maturation of monocytes ... of blood cancer is generally considered to be acute myeloid leukemia (AML). AML has a survival rate of 31.7% ...

It is important for B-cell maturation, proliferation ... chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML) and activated B-cell–diffuse large B-cell lymphoma.

Acute Myeloid Leukemia (AML) remains one of the most ... The development and maturation of NK cells are tightly regulated by ...